コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ng carbapenem-resistant Escherichia coli and methicillin-resistant Staphylococcus aureus).
2 The wounds were infected with methicillin-resistant Staphylococcus aureus.
3 acting healthcare-associated infections like methicillin-resistant Staphylococcus aureus.
4 bacteria including Clostridium difficile and methicillin-resistant Staphylococcus aureus.
5 ial infections, particularly those caused by methicillin-resistant Staphylococcus aureus.
6 gainst high-priority human pathogens such as methicillin-resistant Staphylococcus aureus.
7 range of gram-positive pathogens, including methicillin-resistant Staphylococcus aureus.
8 ded antibiotic that is highly potent against methicillin-resistant Staphylococcus aureus.
9 ICUs are a major reservoir of methicillin-resistant Staphylococcus aureus.
10 sitive infections, including those caused by methicillin-resistant Staphylococcus aureus.
11 obacteriaceae, and methicillin-sensitive and methicillin-resistant Staphylococcus aureus.
12 resistant strains such as community-acquired methicillin-resistant Staphylococcus aureus.
13 afloxacin is an option for infections due to methicillin-resistant Staphylococcus aureus.
14 dermal inoculation with community-associated methicillin-resistant Staphylococcus aureus.
15 0 with the emergence of community-associated methicillin-resistant Staphylococcus aureus.
16 amycins, both of which have activity against methicillin-resistant Staphylococcus aureus.
17 eutropenic mouse thigh infection model using methicillin-resistant Staphylococcus aureus.
18 numerous Gram-positive pathogens, including methicillin-resistant Staphylococcus aureus, a common ca
19 oncern, especially regarding the outbreak of methicillin-resistant Staphylococcus aureus, a common ca
21 atient with two episodes of cutaneous USA300 methicillin-resistant Staphylococcus aureus abscess.
22 icrobial use [all antimicrobial agents, anti-methicillin-resistant Staphylococcus aureus agents (anti
24 show no significant toxicity to the bacteria methicillin-resistant Staphylococcus aureus and Escheric
26 y against gram-positive pathogens, including methicillin-resistant Staphylococcus aureus and isolates
27 resulted in 3 log and 2.6 log reductions of methicillin-resistant Staphylococcus aureus and Pseudomo
28 Efficacy outcomes by pathogen, including methicillin-resistant Staphylococcus aureus and the freq
29 bial resistance, including increased risk of methicillin-resistant Staphylococcus aureus and vancomyc
30 ties against Gram-positive strains including methicillin-resistant Staphylococcus aureus and vancomyc
31 ounds possess excellent activity against FQR methicillin-resistant Staphylococcus aureus and vancomyc
32 ting revealed antibacterial activity against methicillin-resistant Staphylococcus aureus , and chemic
33 th various bacterial strains including MRSA (methicillin-resistant Staphylococcus aureus) and ESBL-EC
34 ro activity against gram-positive (including methicillin-resistant Staphylococcus aureus) and gram-ne
35 beta-lactamase-producing Enterobacteriaceae, methicillin-resistant Staphylococcus aureus, and vancomy
36 icrobial use (all antimicrobial agents, anti-methicillin-resistant Staphylococcus aureus [anti-MRSA]
38 cals, and other drug-resistant strains, like methicillin-resistant Staphylococcus aureus, as well as
39 activity against Listeria monocytogenes and methicillin-resistant Staphylococcus aureus at concentra
40 included (mean age, 59 yr); of them, 33% had methicillin-resistant Staphylococcus aureus bacteremia.
41 titutions on the antibiofilm activity toward methicillin resistant Staphylococcus aureus biofilms was
42 of carbapenem-resistant Escherichia coli and methicillin-resistant Staphylococcus aureus by recognizi
47 tions (SSTIs) caused by community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) ha
50 ric index patients with community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) SS
51 ing the last 2 decades, community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) st
52 ineage of hypervirulent, community-acquired, methicillin-resistant Staphylococcus aureus (CA-MRSA) wi
53 mportant role in treating community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA), r
54 target infections with community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA), w
55 dren with the spread of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA).
56 ococcal disease caused by community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA).
57 vious investigations of community-associated methicillin-resistant Staphylococcus aureus(CA-MRSA) iso
58 et al. (Nature 2018;563:705-709) report that methicillin-resistant Staphylococcus aureus camouflages
59 stant bacterial clinical isolates, including methicillin-resistant Staphylococcus aureus, carbapenem-
61 abled low limits of detection (316 copies of methicillin-resistant Staphylococcus aureus DNA) in our
63 l colonization with sfb were challenged with methicillin-resistant Staphylococcus aureus in an acute
64 ental ventilator-associated pneumonia due to methicillin-resistant Staphylococcus aureus in rats.
65 nt of ventilator-associated pneumonia due to methicillin-resistant Staphylococcus aureus in rats.Meth
66 nces clearance of the leading human pathogen methicillin-resistant Staphylococcus aureus in vivo.
67 discrimination between unrelated strains of methicillin-resistant Staphylococcus aureus, indicating
68 n significantly hastened healing in ischemic methicillin-resistant Staphylococcus aureus infected del
70 e and predisposing to Clostridium difficile, methicillin-resistant Staphylococcus aureus infections a
72 nant strategy; it averted 1.31% and 1.59% of methicillin-resistant Staphylococcus aureus infections o
73 afety for patients being treated for serious methicillin-resistant Staphylococcus aureus infections.
74 was similar for methicillin-susceptible and methicillin-resistant Staphylococcus aureus infections.
75 ntly (P = .002) and there was an increase in methicillin-resistant Staphylococcus aureus keratitis.
77 tibiotic candidate for the treatment of both methicillin resistant Staphylococcus aureus (MRSA) and v
78 either human blood or human blood with added methicillin resistant Staphylococcus aureus (MRSA) for 9
79 f the the most dominant nosocomial bacteria, Methicillin Resistant Staphylococcus aureus (MRSA) have
81 use in practice by analyzing a collection of methicillin resistant Staphylococcus aureus (MRSA) isola
82 untries have demonstrated emergence of novel methicillin resistant Staphylococcus aureus (MRSA) strai
85 ion and factors associated with clearance of methicillin-resistant Staphylococcus aureus (MRSA) after
87 lts in synergistic in vitro activity against methicillin-resistant Staphylococcus aureus (MRSA) and b
90 re changes and microbicidal activity against methicillin-resistant Staphylococcus aureus (MRSA) and E
92 on of antibiotic-resistant organisms such as methicillin-resistant Staphylococcus aureus (MRSA) and o
93 activity against bacterial strains including methicillin-resistant Staphylococcus aureus (MRSA) and p
95 agent, binds to the terminal peptide of the methicillin-resistant staphylococcus aureus (MRSA) and s
96 nces lyse bacteria including the "superbugs" methicillin-resistant Staphylococcus aureus (MRSA) and v
97 showed moderate antibiotic activity against methicillin-resistant Staphylococcus aureus (MRSA) and v
98 committee has prioritized projects involving methicillin-resistant Staphylococcus aureus (MRSA) and v
99 istance among bacterial pathogens, including methicillin-resistant Staphylococcus aureus (MRSA) and v
100 target bacterial cell wall biosynthesis, but methicillin-resistant Staphylococcus aureus (MRSA) and v
101 nt Gram-positive bacterial infections, e.g., methicillin-resistant Staphylococcus aureus (MRSA) and v
104 Hospitalized patients who are colonized with methicillin-resistant Staphylococcus aureus (MRSA) are a
106 imen, although there were more patients with methicillin-resistant Staphylococcus aureus (MRSA) at ba
108 ycin and antistaphylococcal beta-lactams for methicillin-resistant Staphylococcus aureus (MRSA) bacte
109 hotocatalytic antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA) bacte
111 hought sufficient, we present three cases of methicillin-resistant Staphylococcus aureus (MRSA) bacte
113 mycin exposure and outcomes in patients with methicillin-resistant Staphylococcus aureus (MRSA) bacte
114 ole of the host in development of persistent methicillin-resistant Staphylococcus aureus (MRSA) bacte
115 d WGS screening program of all first-episode methicillin-resistant Staphylococcus aureus (MRSA) blood
117 rea under the curve (PAP-AUC) of consecutive methicillin-resistant Staphylococcus aureus (MRSA) blood
120 ng for all patients plus mupirocin for known methicillin-resistant Staphylococcus aureus (MRSA) carri
125 increases the risk of sequence type (ST) 398 methicillin-resistant Staphylococcus aureus (MRSA) colon
127 (HAP) due to gram-positive pathogens such as methicillin-resistant Staphylococcus aureus (MRSA) conti
128 al specimen collection device to be used for methicillin-resistant Staphylococcus aureus (MRSA) detec
129 d treatment and suggested to be effective in Methicillin-resistant Staphylococcus aureus (MRSA) elimi
131 e clinical efficacy and minimize toxicity in methicillin-resistant Staphylococcus aureus (MRSA) for v
132 d Kingdom MRSA database containing over 1000 methicillin-resistant Staphylococcus aureus (MRSA) genom
133 tive pilot study to evaluate the analysis of methicillin-resistant Staphylococcus aureus (MRSA) genom
134 nyltransferase (MenA) was targeted to reduce methicillin-resistant Staphylococcus aureus (MRSA) growt
136 The recent spread of community-acquired methicillin-resistant Staphylococcus aureus (MRSA) has b
142 s, and the emergence of community-associated methicillin-resistant Staphylococcus aureus (MRSA) has r
144 ad infections with community-associated (CA) methicillin-resistant Staphylococcus aureus (MRSA) have
145 -infected individuals who are colonized with methicillin-resistant Staphylococcus aureus (MRSA) have
146 confirm or refute hospital/ward outbreaks of methicillin-resistant Staphylococcus aureus (MRSA) ident
148 plemented an active surveillance program for methicillin-resistant Staphylococcus aureus (MRSA) in 20
150 R assays were validated for the detection of methicillin-resistant Staphylococcus aureus (MRSA) in ES
151 With the emergence of community-associated methicillin-resistant Staphylococcus aureus (MRSA) in th
157 We report a new approach to the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infec
158 the decrease in hospitalizations related to methicillin-resistant Staphylococcus aureus (MRSA) infec
160 ive antibiotic delivery for the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infec
163 Athletes are a vulnerable population for methicillin-resistant Staphylococcus aureus (MRSA) infec
165 gnificant progress has been made in reducing methicillin-resistant Staphylococcus aureus (MRSA) infec
166 ed States, an epidemic of community-acquired methicillin-resistant Staphylococcus aureus (MRSA) infec
167 New drugs are desperately needed to combat methicillin-resistant Staphylococcus aureus (MRSA) infec
168 red to vancomycin, showed higher activity in methicillin-resistant Staphylococcus aureus (MRSA) infec
185 an antibody which neutralizes alpha-toxin of methicillin-resistant Staphylococcus aureus (MRSA) is ge
186 Discovery of new antibiotics for combating methicillin-resistant Staphylococcus aureus (MRSA) is of
191 condition in the era of community-associated methicillin-resistant Staphylococcus aureus (MRSA) is un
192 ic regimens in the era of community-acquired methicillin-resistant Staphylococcus aureus (MRSA) is un
193 ferral Veterinary Hospital and identified 81 methicillin-resistant Staphylococcus aureus (MRSA) isola
194 arceration transmission networks.We examined methicillin-resistant Staphylococcus aureus (MRSA) isola
195 and Etest, was prospectively assessed for 10 methicillin-resistant Staphylococcus aureus (MRSA) isola
196 curate low-throughput clinical sequencing of methicillin-resistant Staphylococcus aureus (MRSA) isola
198 erial factors that may improve management of methicillin-resistant Staphylococcus aureus (MRSA) nosoc
199 ble to control the systemic dissemination of methicillin-resistant Staphylococcus aureus (MRSA) or Sa
200 ong bias for sequencing epidemic lineages of methicillin-resistant Staphylococcus aureus (MRSA) over
202 utperforms combination treatments in killing methicillin-resistant Staphylococcus aureus (MRSA) persi
204 segregates positive and negative chromogenic methicillin-resistant Staphylococcus aureus (MRSA) plate
209 orthopedics) and perception of high facility methicillin-resistant Staphylococcus aureus (MRSA) preva
210 s Health Administration (VHA) introduced the Methicillin-Resistant Staphylococcus aureus (MRSA) Preve
211 Yet, contact precautions for patients with methicillin-resistant Staphylococcus aureus (MRSA) remai
214 ed from patients who were undergoing routine methicillin-resistant Staphylococcus aureus (MRSA) scree
215 decolonization strategies for the control of methicillin-resistant Staphylococcus aureus (MRSA) selec
216 kflows and applied them to a murine model of methicillin-resistant Staphylococcus aureus (MRSA) sepsi
217 Military trainees are at increased risk for methicillin-resistant Staphylococcus aureus (MRSA) skin
218 ety of Anesthesiologists score, preoperative methicillin-resistant Staphylococcus aureus (MRSA) statu
219 otypically defined community-associated (CA) methicillin-resistant Staphylococcus aureus (MRSA) strai
220 e activation of proinflammatory signaling by methicillin-resistant Staphylococcus aureus (MRSA) strai
221 The rapid emergence and dissemination of methicillin-resistant Staphylococcus aureus (MRSA) strai
223 odstream infections and clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA) than
224 ine (DCS) transporter gene cycA resensitized methicillin-resistant Staphylococcus aureus (MRSA) to be
225 gnificant reduction in the production of key methicillin-resistant Staphylococcus aureus (MRSA) toxin
229 global regulator sarA modulates virulence of methicillin-resistant Staphylococcus aureus (MRSA) via r
232 ing) as a DNA biosensor for the detection of methicillin-resistant Staphylococcus aureus (MRSA) which
233 erformance of BD Max StaphSR and the rate of methicillin-resistant Staphylococcus aureus (MRSA) with
234 ndemic multi-resistant healthcare-associated methicillin-resistant Staphylococcus aureus (MRSA) with
235 potent antibiotic activity selective toward methicillin-resistant Staphylococcus aureus (MRSA) with
236 last resort for serious infections caused by methicillin-resistant Staphylococcus aureus (MRSA)(1,2).
237 nce strategy for bacterial pathogens such as methicillin-resistant Staphylococcus aureus (MRSA)(1-3).
238 y against important Gram-positive (including methicillin-resistant Staphylococcus aureus (MRSA)) and
239 e prevalence rates of Clostridium difficile, methicillin-resistant Staphylococcus aureus (MRSA), and
240 l site infections (SSIs), commonly caused by methicillin-resistant Staphylococcus aureus (MRSA), are
241 The co-beta-peptide is bactericidal against methicillin-resistant Staphylococcus aureus (MRSA), incl
242 am antibiotic for treatment of infections by methicillin-resistant Staphylococcus aureus (MRSA), is a
243 in-susceptible Staphylococcus aureus (MSSA), methicillin-resistant Staphylococcus aureus (MRSA), List
244 E and DE showed to be moderate inhibitors of methicillin-resistant Staphylococcus aureus (MRSA), meth
245 l blood or respiratory cultures positive for methicillin-resistant Staphylococcus aureus (MRSA), Pseu
247 set and community-onset infections caused by methicillin-resistant Staphylococcus aureus (MRSA), vanc
248 llin-sensitive Staphylococcus aureus (MSSA), methicillin-resistant Staphylococcus aureus (MRSA), vanc
249 n metagenome sequencing for the detection of methicillin-resistant Staphylococcus aureus (MRSA), vanc
250 inst various drug-resistant bacteria such as methicillin-resistant Staphylococcus aureus (MRSA), vanc
251 Hs/LTACs (18 NHs, 3 LTACs) were screened for methicillin-resistant Staphylococcus aureus (MRSA), vanc
252 ients from 6 NFs (n = 584) were surveyed for methicillin-resistant Staphylococcus aureus (MRSA), vanc
254 antigen that contributes to the virulence of methicillin-resistant Staphylococcus aureus (MRSA), whic
255 ncluding vancomycin- and linezolid-resistant methicillin-resistant Staphylococcus aureus (MRSA), with
258 d exhibit potent antibiotic activity against methicillin-resistant Staphylococcus aureus (MRSA).
260 coccal and staphylococcal bacteria including methicillin-resistant Staphylococcus aureus (MRSA).
262 st beta-lactams, leading to the phenotype of methicillin-resistant Staphylococcus aureus (MRSA).
263 own what factors account for transmission of methicillin-resistant Staphylococcus aureus (MRSA).
264 abscess have increased with the emergence of methicillin-resistant Staphylococcus aureus (MRSA).
265 (1) have been synthesized and tested against methicillin-resistant Staphylococcus aureus (MRSA).
266 ) as an antibiotic effective in vivo against methicillin-resistant Staphylococcus aureus (MRSA).
268 bacter cloacae, Acinetobacter baumannii, and methicillin-resistant Staphylococcus aureus (MRSA).
269 ists also at the allosteric site of PBP2a of methicillin-resistant Staphylococcus aureus (MRSA).
270 des for the treatment of pneumonia caused by methicillin-resistant Staphylococcus aureus (MRSA).
272 tructure-activity relationship (SAR) against methicillin-resistant Staphylococcus aureus (MRSA).
273 ated improved antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA).
274 -spectrum agent with potent activity against methicillin-resistant Staphylococcus aureus (MRSA).
275 SI), including both gram-positive (including methicillin-resistant Staphylococcus aureus [MRSA]) and
276 mycin-resistant Enterococcus faecium (n=19), methicillin-resistant Staphylococcus aureus (n=17), and
277 esistant Pseudomonas aeruginosa (France) and methicillin-resistant Staphylococcus aureus (Northern Ir
278 ent visits were only significantly higher in methicillin-resistant Staphylococcus aureus (OR, 2.80; 9
279 on, or infection with Clostridium difficile, methicillin-resistant Staphylococcus aureus, or vancomyc
280 d, with a particular focus on vancomycin for methicillin-resistant Staphylococcus aureus, penicillin
281 m was to estimate costs and effectiveness of methicillin-resistant Staphylococcus aureus prevention p
282 ncomycin resistant Enterococcus faecalis and methicillin-resistant Staphylococcus aureus respectively
283 recombinase, limits biofilm formation in the methicillin-resistant Staphylococcus aureus strain LAC a
284 hat EVs purified from a community-associated methicillin-resistant Staphylococcus aureus strain were
285 epidemiology of a novel livestock-associated methicillin-resistant Staphylococcus aureus strain, whic
286 displays killing activity against pathogenic methicillin-resistant Staphylococcus aureus strains and
288 berkeleylactone A was tested against several methicillin-resistant Staphylococcus aureus strains, and
289 lpha toxins secreted by community-associated methicillin-resistant Staphylococcus aureus strains.
290 e and many gram-negative bacteria, including methicillin-resistant Staphylococcus aureus, Streptococc
291 how that during a bloodstream infection with methicillin-resistant Staphylococcus aureus, the majorit
292 ive cohort study of 1,140 patients harboring methicillin-resistant Staphylococcus aureus, the nasal b
294 tions with the epidemic community-associated methicillin-resistant Staphylococcus aureus USA300 is to
295 nst common gram-positive pathogens including methicillin-resistant Staphylococcus aureus, vancomycin-
298 scherichia coli, Salmonella typhimurium, and methicillin-resistant Staphylococcus aureus) were succes
299 pacia J2315, Mycobacterium tuberculosis, and methicillin-resistant Staphylococcus aureus, whereas AGS
300 tration of 10(7) CFU/mL and 95.4 +/- 1.0% of Methicillin-resistant Staphylococcus aureus with startin